PPMS: Predictors of Disease Progression Still Unknown
Failure to find reliable progression predictors makes individualized risk counseling difficult, highlights the shortcomings of the EDSS, and may complicate future PPMS clinical trials
Failure to find reliable progression predictors makes individualized risk counseling difficult, highlights the shortcomings of the EDSS, and may complicate future PPMS clinical trials
None of the variables analyzed in a large cohort of patients with primary-progressive multiple sclerosis predicted...
Clinical Research